Home » Grants/Awards » R01CA239227-A1, NIH/NCI – FOXM1 inhibition: A novel therapeutic avenue for treating breast cancers.

R01CA239227-A1, NIH/NCI – FOXM1 inhibition: A novel therapeutic avenue for treating breast cancers.

2020/01/15-2025/01/01

R01CA239227-A1, NIH/NCI

Manjeet Rao (PI)

Project Goal: To test the hypothesis that FOXM1 plays a critical role in supporting the rescue DNA repair pathways in breast cancers.

Role: PI